Recent Posts
- Cycle Announces the Appointment of Angela Kurtz as Clinical Metabolic Director to lead its newly created Clinical Metabolic Department
- Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in Israel
- US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients
- Dr David Buckeridge Joins Cycle Pharmaceuticals’ Board of Directors
- Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020
Archives
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- Cycle Announces the Appointment of Angela Kurtz as Clinical Metabolic Director to lead its newly created Clinical Metabolic Department
- Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in Israel
- US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients
- Dr David Buckeridge Joins Cycle Pharmaceuticals’ Board of Directors
- Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020
Recent Comments